88536 20210902121631.0 doi 10.1186/s12902-019-0478-9 sideral 117211 ART-2020-117211 eng Manios, Y. Two-stage, school and community-based population screening successfully identifies individuals and families at high-risk for type 2 diabetes: The Feel4Diabetes-study 2020 Access copy available to the general public Unrestricted Background: The implementation of population screening and early prevention strategies targeting individuals at high-risk for type 2 diabetes (T2D) seems to be a public health priority. The current work aimed to describe the screening procedure applied in the Feel4Diabetes-study and examine its effectiveness in identifying individuals and families at high risk, primarily for T2D and secondarily for hypertension, among vulnerable populations in low to middle-income countries (LMICs) and high-income countries (HICs) across Europe. Methods: A two-stage screening procedure, using primary schools as the entry-point to the community, was applied in low socioeconomic status (SES) regions in LMICs (Bulgaria-Hungary), HICs (Belgium-Finland) and HICs under austerity measures (Greece-Spain). During the first-stage screening via the school-setting, a total of 20, 501 parents (mothers and/or fathers) of schoolchildren from 11, 396 families completed the Finnish Diabetes Risk Score (FINDRISC) questionnaire, while their children underwent anthropometric measurements in the school setting. Parents from the identified "high-risk families" (n = 4484) were invited to participate in the second-stage screening, including the measurement of fasting plasma glucose (FPG) and blood pressure (BP). In total, 3153 parents participated in the second-stage screening (mean age 41.1 ± 5.6 years, 65.8% females). Results: Among parents who attended the second-stage screening, the prevalence of prediabetes (as defined by impaired fasting glucose; FPG 100-125 mg/dl) and T2D (FPG > 126 mg/dl) was 23.2 and 3.0% respectively, and it was found to be higher in the higher FINDRISC categories. The percentage of undiagnosed T2D among the participants identified with T2D was 53.5%. The prevalence of high normal BP (systolic BP 130-139 mmHg and/or diastolic BP 85-89 mmHg) and hypertension (systolic BP = 140 mmHg and/or diastolic BP = 90 mmHg) was 14 and 18.6% respectively, which was also higher in the higher FINDRISC categories. The percentage of cases not receiving antihypertensive treatment among the participants identified with hypertension was 80.3%. Conclusion: The findings of the current study indicate that the two-stage school and community-based screening procedure followed, effectively identified high-risk individuals and families in vulnerable populations across Europe. This approach could be potentially scalable and sustainable and support initiatives for the early prevention of T2D and hypertension. info:eu-repo/grantAgreement/EC/H2020/643708/EU/Developing and implementing a community-based intervention to create a more supportive social and physical environment for lifestyle changes to prevent diabetes in vulnerable families across Europe/Feel4Diabetes This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement No H2020 643708-Feel4Diabetes info:eu-repo/semantics/openAccess by http://creativecommons.org/licenses/by/3.0/es/ 2.763 2020 ENDOCRINOLOGY & METABOLISM 110 / 145 = 0.759 2020 Q4 T3 0.743 2020 Medicine (miscellaneous) 2020 Q2 Endocrinology, Diabetes and Metabolism 2020 Q2 info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Mavrogianni, C. Lambrinou, C.P. Cardon, G. Lindström, J. Iotova, V. Tankova, T. Civeira, F. Universidad de Zaragoza (orcid)0000-0001-7043-0952 Kivelä, J. Jancsó, Z. Shadid, S. Tsochev, K. Mateo-Gallego, R. Universidad de Zaragoza (orcid)0000-0001-6650-8294 Radó, S. Dafoulas, G. Makrilakis, K. Androutsos, O. 1006 255 Universidad de Zaragoza Dpto. Fisiatría y Enfermería Área Enfermería 1007 610 Universidad de Zaragoza Dpto. Medicina, Psiqu. y Derm. Area Medicina 20, Suppl 1 (2020), 12 [11 pp.] BMC ENDOCRINE DISORDERS BMC endocrine disorders 1472-6823 861280 http://zaguan.unizar.es/record/88536/files/texto_completo.pdf Versión publicada 47414 http://zaguan.unizar.es/record/88536/files/texto_completo.jpg?subformat=icon icon Versión publicada oai:zaguan.unizar.es:88536 articulos driver 2021-09-02-08:52:59 ARTICLE